Skip to main content
Vai all'homepage della Commissione europea (si apre in una nuova finestra)
italiano it
CORDIS - Risultati della ricerca dell’UE
CORDIS

mapping the sequence determinants of protein stability and its contribution to rare genetic diseases

Obiettivo

Missense variants cause nearly one-third of all human genetic diseases, yet most have unknown functional consequences. Computational predictors can flag pathogenic variants, but they remain blind to mechanism—whether a mutation destabilizes a protein, mislocalizes it, or alters its interactions. Without mechanism, variant interpretation is incomplete and therapeutic opportunities remain hidden. I previously developed deep mutational scanning (DMS) methods to quantify the effects of >500,000 variants on the stability of >500 human protein domains, revealing that ~50% of pathogenic variants destabilize proteins. Yet this still covers barely 1% of domains and 2% of unique folds in human. Most of the proteome—including most rare disease proteins—remains experimentally unexplored.
Here, we will expand this approach to decode how protein stability is encoded in sequence and how its loss contributes to rare genetic diseases. Specifically, we will:

1) Chart the landscape of protein fold stability — generating the broadest DMS survey of fold space to date, covering 800 unique folds to uncover the sequence determinants of stability and refine predictive models.
2) Expand stability mapping to full-length proteins in human cells — by generating DMS maps across 500 rare disease proteins, we will reveal how mutations in domains, linkers, and disordered regions shape protein abundance in cells, and test the specificity of stabilizer drugs.
3) Dissect how the proteostasis network shapes disease variant outcomes —by systematically mapping how chaperones and degradation pathways interact with mutations, we will reveal variants whose effects emerge under proteostasis decline.

These datasets will serve as reference atlases for clinical variant interpretation across rare diseases— defining which are ‘folding diseases’, and which pathogenic variants are destabilizing—and collectively transform our understanding of how protein stability—and its failure—is encoded in the human genome.

Campo scientifico (EuroSciVoc)

Questo progetto non è ancora stato classificato con EuroSciVoc.
Suggerisci i campi scientifici che ritieni più rilevanti e aiutaci a migliorare il nostro servizio di classificazione.

Parole chiave

Programma(i)

Argomento(i)

Meccanismo di finanziamento

HORIZON-ERC - HORIZON ERC Grants

Vedi tutti i progetti finanziati nell’ambito di questo schema di finanziamento

Invito a presentare proposte

(si apre in una nuova finestra) ERC-2026-STG

Vedi tutti i progetti finanziati nell’ambito del bando

Istituzione ospitante

AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS
Contributo netto dell'UE
€ 1 625 000,00
Indirizzo
CALLE SERRANO 117
28006 Madrid
Spagna
Regione
Comunidad de Madrid Comunidad de Madrid Madrid
Tipo di attività
Research Organisations
Collegamenti
Costo totale
€ 1 625 000,00

Beneficiari (1)